AVEO PHARMACEUTICALS INC (AVEO)
US0535883070 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 77.40M | 70.54M | 61.80M | 29.80M | 24.40M | |||
| Marketable Securities | 0.00 | 16.78M | 0.00 | 18.00M | 0.00 | |||
| Receivables | 19.76M | 11.60M | 1.20M | 1.60M | 3.00M | |||
| Inventories | 1.11M | 1.66M | N/A | N/A | N/A | |||
| Other Current Assets | 2.46M | 4.15M | 2.60M | 1.20M | 500.00K | |||
| Total Current Assets | 100.73M | 104.74M | 65.50M | 50.60M | 27.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 257.00K | 454.00K | 1.20M | N/A | N/A | |||
| Other Non-Current Assets | 245.00K | 151.00K | 200.00K | N/A | 0.00 | |||
| Total Non-Current Assets | 502.00K | 605.00K | 1.40M | 0.00 | 0.00 | |||
| TOTAL ASSETS | 101.23M | 105.34M | 66.90M | 50.60M | 27.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.49M | 0.00 | 1.10M | 9.60M | 3.30M | |||
| Accrued Expenses | 25.89M | 15.44M | 9.40M | 8.00M | 9.00M | |||
| Accounts Payable | 5.04M | 2.71M | 3.40M | 1.50M | 3.50M | |||
| Other Current Liabilities | 0.00 | 578.00K | 3.10M | 2.10M | 2.40M | |||
| Total Current Liabilities | 42.42M | 18.73M | 16.90M | 21.10M | 18.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 27.18M | 37.96M | 12.70M | 6.20M | 15.80M | |||
| Other Non-Current Liabilities | 2.78M | 2.78M | 2.00M | 8.40M | 21.30M | |||
| Total Non-Current Liabilities | 29.96M | 40.74M | 14.70M | 14.70M | 37.10M | |||
| TOTAL LIABILITIES | 72.39M | 59.47M | 31.60M | 35.80M | 55.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -696.33M | -674.55M | -621.20M | -585.60M | -595.00M | |||
| Additional Paid In Capital | 725.14M | 720.39M | 656.50M | 600.30M | 567.70M | |||
| Common Shares | 35.00K | 34.00K | 0.00 | 200.00K | 100.00K | |||
| Other Shareholders' Equity | 0.00 | -3.00K | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 34.62M | 34.47M | 26.90M | 16.10M | 12.60M | |||
| Tangible Book Value per Share | 0.83 | 1.33 | 1.31 | 0.92 | -2.16 | |||
| Total Shareholders' Equity | 28.84M | 45.87M | 35.30M | 14.80M | -27.20M | |||
| TOTAL LIABILITIES AND EQUITY | 101.23M | 105.34M | 66.90M | 50.60M | 27.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.94 | 0.83 | 0.36 | 0.42 | -0.58 | |||
| Current Ratio | 2.37 | 5.59 | 3.88 | 2.40 | 1.54 | |||
| Return On Assets (ROA) | -28.69% | -50.64% | -53.21% | 18.58% | -19.00% | |||
| Return On Equity (ROE) | -100.67% | -116.29% | -100.85% | 63.51% | N/A | |||
All data in USD